Farm & Ranch News

… technology domain for creating agri-preneures. Agriculture is the largest … greenhouse farming, organic farming, agricultural biotechnology, soil technology and testing … promote climate-resilient agriculture in vulnerable districts, agricultural value chains, …

With EIN Presswire press release distribution services you will reach decision makers and journalists plus get valuable SEO benefits.

… employed in the food or agriculture sector would be able to …

… Large-scale installation of agrivoltaic systems, a term … College of Agricultural Sciences, says that agrivoltaics provide a … Higgins: “Rural America, agriculture in particular, can be … got him thinking about agrivoltaic research. Early research focused …

Westport Fuel Systems WPRT recently announced that it will commence a research project with Scania to apply its high-pressure direct injection (HPDI) 2.0 fuel system using hydrogen to the latter’s latest internal combustion engine (ICE). Preliminary test results will likely be

Burning Rock Biotech Limited BNR was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the st

Westport Fuel Systems WPRT recently announced that it will commence a research project with Scania to apply its high-pressure direct injection (HPDI) 2.0 fuel system using hydrogen to the latter’s latest internal combustion engine (ICE). Preliminary test results will likely be

Burning Rock Biotech Limited BNR was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the st

This week the FDA approved Merck MRK and Bayer’s BAYRY new heart failure drug, vericiguat and Glaxo GSK/J&J’s JNJ long-acting regimen for HIV treatment, Cabenuva. The FDA also gave the green signal to AstraZeneca’s AZN Enhertu and J&J’s Darzalex Faspro for new ind

This week the FDA approved Merck MRK and Bayer’s BAYRY new heart failure drug, vericiguat and Glaxo GSK/J&J’s JNJ long-acting regimen for HIV treatment, Cabenuva. The FDA also gave the green signal to AstraZeneca’s AZN Enhertu and J&J’s Darzalex Faspro for new ind

Xilinx XLNX is expected to report third-quarter fiscal 2021 results on Jan 26.

F5 Networks FFIV is set to report first-quarter fiscal 2021 results on Jan 26.

Xilinx XLNX is expected to report third-quarter fiscal 2021 results on Jan 26.

F5 Networks FFIV is set to report first-quarter fiscal 2021 results on Jan 26.

Huntington Bancshares (HBAN) came out with quarterly earnings of $0.27 per share, missing the Zacks Consensus Estimate of $0.30 per share. This compares to earnings of $0.28 per share a year ago. These figures are adjusted for non-recurring items.

Huntington Bancshares (HBAN) came out with quarterly earnings of $0.27 per share, missing the Zacks Consensus Estimate of $0.30 per share. This compares to earnings of $0.28 per share a year ago. These figures are adjusted for non-recurring items.

People's United Financial PBCT delivered fourth-quarter 2020 operating earnings of 35 cents per share, beating the Zacks Consensus Estimate of 32 cents. The reported figure, however, comes in below the prior-year quarter figure of 37 cents.Rise in revenues, aided by high fee inco

People's United Financial PBCT delivered fourth-quarter 2020 operating earnings of 35 cents per share, beating the Zacks Consensus Estimate of 32 cents. The reported figure, however, comes in below the prior-year quarter figure of 37 cents.Rise in revenues, aided by high fee inco

Lam Research Corporation LRCX is slated to report second-quarter fiscal 2021 results on Jan 27. In the last reported quarter, the company delivered an earnings surprise of 9.7%.Lam Research’s surprise history has been decent. The company surpassed earnings estimates in three ou

Texas Capital Bancshares TCBI reported adjusted earnings per share of $1.14 in fourth-quarter 2020, inching past the Zacks Consensus Estimate of $1.13. However, results compare unfavorably with the prior-year quarter’s $1.23.Rise in fee income and lower expenses were driving fa